CRTD (Creatd Inc.) Sells Remaining 80% of Fly Flyte to NYSE-Listed VTAK (Catheter Precision Inc.), Securing Significant Cash and Equity Position
NEW YORK, March 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK). Under the terms of the completed transaction, Creatd will receive […]
VTAK Acquires 20% Interest in Creatd’s Subsidiary Fly Flyte, Inc.
New York, NY, Feb. 17, 2026, – PRISM MediaWire (Press Release Service – Press Release Distribution) – Creatd, Inc. (OTCQB: CRTD) announced that Catheter Precision, Inc. (NYSE American: VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd’s strategy […]
Catheter Precision, Inc. Receives CE Mark for LockeT
Opens Multi-Billion Market Opportunity for the Company First Order for 100 Units Received FORT MILL, S.C., May 27, 2025 – PRISM MediaWire – Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that it has received CE Mark approval for […]
Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy
BRIDGEWATER, NJ, February 10, 2025 – PRISM MediaWire – Catheter Precision Inc. (NYSE American: VTAK) (“Catheter Precision” or the “Company”), a U.S.-based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, today announced its engagement with PCG Advisory, a leading investor relations, strategic communications, and digital strategies firm, to enhance […]